Market Cap : 437.27 B | Enterprise Value : 440.81 B | PE Ratio : 24.22 | PB Ratio : 5.73 |
---|
NYSE:JNJ has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
NYSE:JNJ has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Johnson & Johnson's average Accounts Payable for the three months ended in Jun. 2022 was $9,537 Mil. Johnson & Johnson's Cost of Goods Sold for the three months ended in Jun. 2022 was $7,919 Mil. Hence, Johnson & Johnson's Days Payable for the three months ended in Jun. 2022 was 109.89.
The historical rank and industry rank for Johnson & Johnson's Days Payable or its related term are showing as below:
During the past 13 years, Johnson & Johnson's highest Days Payable was 125.68. The lowest was 97.38. And the median was 109.01.
JNJ's Days Payable is ranked better thanJohnson & Johnson's Days Payable increased from Jun. 2021 (103.48) to Jun. 2022 (109.89). It may suggest that Johnson & Johnson delayed paying its suppliers.
The historical data trend for Johnson & Johnson's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - General subindustry, Johnson & Johnson's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Drug Manufacturers industry and Healthcare sector, Johnson & Johnson's Days Payable distribution charts can be found below:
* The bar in red indicates where Johnson & Johnson's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Johnson & Johnson's Days Payable for the fiscal year that ended in Dec. 2021 is calculated as
Days Payable (A: Dec. 2021 ) | |||||||||
= | Average Accounts Payable | / | Cost of Goods Sold | * | Days in Period | ||||
= | ( (Accounts Payable (A: Dec. 2020 ) | + | Accounts Payable (A: Dec. 2021 )) | / | count ) | / | Cost of Goods Sold (A: Dec. 2021 ) | * | Days in Period |
= | ( (9505 | + | 11055) | / | 2 ) | / | 29855 | * | 365 |
= | 10280 | / | 29855 | * | 365 | ||||
= | 125.68 |
Johnson & Johnson's Days Payable for the quarter that ended in Jun. 2022 is calculated as:
Days Payable (Q: Jun. 2022 ) | |||||||||
= | Average Accounts Payable | / | Cost of Goods Sold | * | Days in Period | ||||
= | ( (Accounts Payable (Q: Mar. 2022 ) | + | Accounts Payable (Q: Jun. 2022 )) | / | count ) | / | Cost of Goods Sold (Q: Jun. 2022 ) | * | Days in Period |
= | ( (9309 | + | 9765) | / | 2 ) | / | 7919 | * | 365 / 4 |
= | 9537 | / | 7919 | * | 365 / 4 | ||||
= | 109.89 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Thank you for viewing the detailed overview of Johnson & Johnson's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.
Adamczyk Darius | director | 855 S. MINT STREET CHARLOTTE NC 28202 |
Hait William | officer: See Remarks | ONE JOHNSON & JOHNSON PLAZA NEW BRUNSWICK NJ 08933 |
Mammen Mathai | officer: EVP, Pharm, R&D | THERAVANCE,INC. 901 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080 |
Broadhurst Vanessa | officer: EVP, Global Corp Aff. | ONE JOHNSON & JOHNSON PLAZA NEW BRUNSWICK NJ 08933 |
Swanson James D. | officer: EVP, Chief Information Officer | ONE JOHNSON & JOHNSON PLAZA NEW BRUNSWICK NJ 08933 |
West Nadja | director | 1915 REXFORD ROAD CHARLOTTE NC 28211 |
Decker Robert J | officer: Controller, CAO | ONE JOHNSON & JOHNSON PLAZA NEW BRUNSWICK NJ 08933 |
Joly Hubert | director | C/O BEST BUY CO, INC. 7601 PENN AVENUE SOUTH RICHFIELD MN 55423 |
Weinberger Mark A | director | METLIFE, INC. 200 PARK AVENUE NEW YORK NY 10166 |
Hewson Marillyn A | director | C/O CARPENTER TECHNOLOGY CORPORATION PO BOX 14662 READING PA 19612-4662 |
Mongon Thibaut | officer: Exec VP, WW Chair, Consumer | JOHNSON & JOHNSON ONE JOHNSON & JOHNSON PLAZA NEW BRUNSWICK NJ 08933 |
Wengel Kathryn E | officer: EVP, Chief GSC Officer | JOHNSON & JOHNSON ONE JOHNSON & JOHNSON PLAZA NEW BRUNSWICK NJ 08933 |
Wolk Joseph J | officer: Exec VP, CFO | JOHNSON & JOHNSON ONE JOHNSON & JOHNSON PLAZA NEW BRUNSWICK NJ 08933 |
Mcevoy Ashley | officer: EVP, WW Chair, Medical Devices | JOHNSON & JOHNSON ONE JOHNSON & JOHNSON PLAZA NEW BRUNSWICK NJ 08933 |
Taubert Jennifer L | officer: EVP, WW Chair, Pharmaceuticals | JOHNSON & JOHNSON ONE JOHNSON & JOHNSON PLAZA NEW BRUNSWICK NJ 08933 |
From GuruFocus
Other Sources
By Zacks 2022-04-04
By Zacks 2022-03-21
By Zacks 2022-03-16
By Zacks 2022-03-14
By Zacks 2022-03-18
By Zacks 2022-03-14
By tipranks.com 2022-04-01
By Zacks 2022-03-21
By Zacks 2022-03-16
By Zacks 2022-03-28
By Zacks 2022-03-22
By Zacks 2022-04-06
By Zacks 2022-04-04
By Zacks 2022-03-25
By tipranks.com 2022-03-16